Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma-Reference-Cited by-同舟云学术

Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma

Published:2021-10 Issue:5 Volume:60 Page:103197
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Heider Michael,Grass Sandra,Dill Veronika^ORCID,Rämisch Stephanie,Winter Christof,Verbeek Mareike,Götze Katharina S.,Bassermann Florian,Jilg Stefanie^ORCID

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. NCCN guidelines insights: multiple myeloma, version 3.2018;Kumar;J Natl Compr Canc Netw,2018

2. Meta-analysis to evaluate high-dose therapy followed by stem cell transplant in patients with multiple myeloma-reply;Dhakal;JAMA Oncol,2018

3. Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma;Sahin;J Clin Apher,2018

4. UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy;Douglas;J Clin Apher,2018

5. International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100);Giralt;Leukemia,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G‐CSF versus G‐CSF only: A single‐center retrospective analysis;Transfusion;2024-04-10

2. Therapeutic Effect and Adverse Event Rate of Different Treatment Methods in Patients with Multiple Myeloma and Renal Insufficiency;International Archives of Allergy and Immunology;2024

3. Cyclophosphamide/etoposide;Reactions Weekly;2021-11